Arcutis Biotherapeutics has a lofty goal for 2025 — and it could help Arcutis stock continue a massive run that helped shares ...

Age at initiation of treatment and the type of biologic therapy prescribed effect the rate of drug survival among patients with psoriasis.

Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the population and is mediated ...

Published results showed “Latine” patients with psoriasis in the U.S. have unique experiences with their disease and ...

Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal ...

The use of biologics in psoriasis and psoriatic arthritis management is not linked to the risk of cardiovascular or venous thromboembolic events.

The team, led by Hye Sun Gwak, analyzed data from 13 studies and found that several types of blood pressure medications—ACE ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

Drugmakers raised the list prices of more than 800 prescription drugs for blood pressure, cancer and other conditions by a ...

Among 2024’s notable new drugs were three approvals for antibiotic therapies: Allecra Therapeutics’ Exblifep (cefepime and enmetazobactam), Basilea Pharmaceutica’s Zevtera (ceftobiprole ...